Zhejiang Tianyu Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000034X1
  • SHE: 300702
CNY
21.74
0.54 (2.55%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
1,199.06
811.67
774.15
719.55
808.11
754.16
698.60
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,199.06
811.67
774.15
719.55
808.11
754.16
698.60
Raw Material Cost
885.21
577.13
559.98
449.92
517.12
499.85
496.52
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
11.57
9.48
9.63
10.90
11.30
11.31
13.21
Selling and Distribution Expenses
139.96
102.26
194.14
110.66
122.18
97.68
163.37
Other Expenses
5.27
3.57
4.29
4.42
4.37
3.42
3.63
Total Expenditure (Excl Depreciation)
1,089.41
724.58
806.69
615.72
694.33
643.05
709.42
Operating Profit (PBDIT) excl Other Income
109.60000000000001
87.10000000000001
-32.5
103.80000000000001
113.80000000000001
111.1
-10.8
Other Income
-5.67
-9.09
-8.01
3.10
9.78
14.49
26.69
Operating Profit (PBDIT)
186.01
157.85
24.48
177.85
163.57
195.78
73.09
Interest
11.57
9.48
9.63
10.90
11.30
11.31
13.21
Exceptional Items
0.72
-0.17
0.72
-0.07
0.15
0.30
-0.34
Gross Profit (PBDT)
313.85
234.53
214.17
269.62
290.99
254.31
202.08
Depreciation
101.77
101.77
91.50
91.50
88.58
88.58
85.85
Profit Before Tax
73.40
46.44
-75.93
75.39
63.84
96.18
-26.30
Tax
10.54
4.24
4.82
3.96
0.36
9.75
1.09
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
61.72
42.19
-81.22
71.42
63.33
86.18
-29.18
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
61.72
42.19
-81.22
71.42
63.33
86.18
-29.18
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.70
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
62.42
42.19
-81.22
71.42
63.33
86.18
-29.18
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,563.69
3,682.12
3,639.62
3,720.29
3,633.81
3,586.12
3,497.77
Earnings per share (EPS)
0.18
0.12
-0.23
0.21
0.18
0.25
-0.08
Diluted Earnings per share
0.18
0.12
-0.23
0.21
0.18
0.25
-0.08
Operating Profit Margin (Excl OI)
7.5%
8.03%
-7.62%
11.57%
8.07%
12.29%
-5.65%
Gross Profit Margin
14.61%
18.26%
2.01%
23.19%
18.86%
24.5%
8.52%
PAT Margin
5.15%
5.2%
-10.49%
9.93%
7.84%
11.43%
-4.18%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 47.73% vs 4.84% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 47.87% vs 151.97% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 14.86% vs 413.54% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 22.11% vs -1.04% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

Compare Quarterly Results Of Zhejiang Tianyu Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,199.06
0
1,199.06
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,199.06
0
1,199.06
Raw Material Cost
885.21
0
885.21
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
11.57
0
11.57
Selling and Distribution Expenses
139.96
0
139.96
Other Expenses
5.27
0.00
5.27
Total Expenditure (Excl Depreciation)
1,089.41
0
1,089.41
Operating Profit (PBDIT) excl Other Income
109.65
0.00
109.65
Other Income
-5.67
0
-5.67
Operating Profit (PBDIT)
186.01
0
186.01
Interest
11.57
0
11.57
Exceptional Items
0.72
0
0.72
Gross Profit (PBDT)
313.85
0
313.85
Depreciation
101.77
0
101.77
Profit Before Tax
73.40
0
73.40
Tax
10.54
0
10.54
Provisions and contingencies
0
0
0.00
Profit After Tax
61.72
0
61.72
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
61.72
0
61.72
Share in Profit of Associates
0
0
0.00
Minority Interest
0.70
0
0.70
Other related items
0.00
0.00
0.00
Consolidated Net Profit
62.42
0
62.42
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,563.69
0
3,563.69
Earnings per share (EPS)
0.18
0
0.18
Diluted Earnings per share
0.18
0
0.18
Operating Profit Margin (Excl OI)
7.50%
0%
0.00
7.50%
Gross Profit Margin
14.61%
0%
0.00
14.61%
PAT Margin
5.15%
0%
0.00
5.15%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 119.91 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 47.73% vs 4.84% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 48.39% vs 40.30% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.24 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 47.87% vs 151.97% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -1.42% vs 398.43% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 19.17 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 14.86% vs 413.54% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 24.64% vs 65.73% in Jun 2025

Quarterly - Interest
Interest 1.16 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 22.11% vs -1.04% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 2.65% vs -11.02% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.50%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025